post-viral syndrome News

Latest Articles

• Clinical Trial Identifies Common Antidepressant Fluvoxamine as Breakthrough Treatment for Chronic Fatigue in Long COVID Patients

  Published: Mar 31, 2026

  Section: Research

  A global study co-led by McMaster University has confirmed that fluvoxamine significantly reduces debilitating fatigue and improves quality of life for those suffering from long CO...